[
    [
        {
            "time": "",
            "orginal_text": "医药生物行业周报：狂犬单抗未来会是大品种吗？再次强调12月是医药底部布局期",
            "features": {
                "keywords": [
                    "狂犬单抗",
                    "大品种",
                    "医药",
                    "底部布局"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业周报：狂犬单抗未来会是大品种吗？再次强调12月是医药底部布局期",
            "scores": {
                "News_content": "医药生物行业周报：狂犬单抗未来会是大品种吗？再次强调12月是医药底部布局期",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业12月月报：静待医药政策落地期 关注重磅品种研发进展和优质细分赛道",
            "features": {
                "keywords": [
                    "医药政策",
                    "重磅品种",
                    "研发进展",
                    "优质细分赛道"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "医药生物行业12月月报：静待医药政策落地期 关注重磅品种研发进展和优质细分赛道",
            "scores": {
                "News_content": "医药生物行业12月月报：静待医药政策落地期 关注重磅品种研发进展和优质细分赛道",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "高瓴资本概念股逆势活跃，广联达、国瓷材料、泰格医药、凯莱英等普涨",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "普涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "高瓴资本概念股逆势活跃，广联达、国瓷材料、泰格医药、凯莱英等普涨",
            "scores": {
                "News_content": "高瓴资本概念股逆势活跃，广联达、国瓷材料、泰格医药、凯莱英等普涨",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业周报：医药反弹OR反抽？",
            "features": {
                "keywords": [
                    "医药",
                    "反弹",
                    "反抽"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "医药行业周报：医药反弹OR反抽？",
            "scores": {
                "News_content": "医药行业周报：医药反弹OR反抽？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业研究周报：从批签发变化来看血制品行业有望迎来高景气度",
            "features": {
                "keywords": [
                    "批签发",
                    "血制品",
                    "高景气度"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业研究周报：从批签发变化来看血制品行业有望迎来高景气度",
            "scores": {
                "News_content": "医药生物行业研究周报：从批签发变化来看血制品行业有望迎来高景气度",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]